Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

FDA Accepts Nuvo’s Resubmission For Pennsaid(R)

By Pharmaceutical Processing | February 19, 2009

Nuvo Research Inc., a Canadian drug development company focused on the research anddevelopment of drug products delivered to and through the skin using itstopical and transdermal drug delivery technologies, today announced that theU.S. Food and Drug Administration (FDA) has accepted Nuvo’s resubmission ofits application for FDA approval to market Pennsaid in the U.S. as a completeresponse to the FDA’s December 28, 2006 Approvable Letter. The FDA hasindicated that it intends to advise Nuvo of its decision regarding Pennsaidapprovability by August 5, 2009 (the “PDUFA Date”) under the Prescription DrugUser Fee Act. Pennsaid, a topical non-steroidal anti-inflammatory drug (NSAID), iscurrently marketed in Canada and several European countries to treat the painand symptoms associated with osteoarthritis. “We are now less than six months away from the anticipated approval ofPennsaid in the U.S.,” said Dr. Henrich Guntermann, President and CEO of NuvoResearch. “We are extremely optimistic about Pennsaid’s potential for approvaland are continuing discussions with potential U.S. licensing partners.”

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE